Key Starting Material News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Key starting material. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Key Starting Material Today - Breaking & Trending Today

India's import of Active Pharmaceutical Ingredients and Key Starting Material from other countries including China grew: Ministry

India's import of Active Pharmaceutical Ingredients and Key Starting Material from other countries including China grew: Ministry
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.

Himachal Pradesh , Lok Sabha , Margani Bharat , Goddeti Madhavi , Pocha Brahmananda Reddy , Ministry Of Chemicals , Health Ministry , Active Pharmaceutical Ingredients , Key Starting Material , Bulk Drug Parks , Bulk Drug , Andhra Pradesh ,

Pharma sector hits upon right formula - The Hindu BusinessLine

Pharma sector hits upon right formula - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Atal Bihari Vajpayee , Abbreviated New Drug Application , Active Pharmaceutical Ingredient , Key Starting Material , Latin America ,

An Immediate Agenda For Health Minister Mansukh Mandaviya

An Immediate Agenda For Health Minister Mansukh Mandaviya
swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.

Shri Mansukh Mandavia , Health Centres Phcs , Ministry Of Health , National Security , Ministry Of Chemicals , Technology Development , Department Of Pharmaceuticals , Health Centres , Central Ministry , Department Of Biotech Pharmaceuticals , Technology Missions , Family Welfare , Production Linked Incentive , Primary Health Centres , Nirbhar Swasth Bharat Yojana , Medical Education Capacity , Central Government , Nursing Schools , Drug Parks , Medical Devices Parks , Bulk Drug Parks , Key Starting Materials , Active Ingredient , Hospital Consumables , Cabinet Approval , Non Rebreather Face Masks ,

Indian gov't waives off import duty on antiviral drug amid COVID-19 spike - World News

2021-04-21 10:06:07 GMT2021-04-21 18:06:07(Beijing Time) Xinhua English
NEW DELHI, April 21 (Xinhua) India s federal government Wednesday announced that it has waived off the import duty on Remdesivir, a broad-spectrum antiviral drug, to provide affordable medical care for the COVID-19 patients, officials said.
The step is aimed at increasing the supply of the drug and reduce the cost which will benefit the patients.
A notification issued by the federal finance ministry said import duty was removed from Remdesivir active pharmaceutical ingredients, injection and specific substances used in the manufacture of Remdesivir.
Considering the immediate requirement on the recommendation of the Department of Pharmaceuticals, the Department of Revenue has waived customs duty on Remdesivir and its Active Pharmaceutical Ingredients (API)/Key Starting Material (KSM). This step will further augment domestic availability of Remdesivir injection, Minister of Chemicals a ....

Dv Sadanand Gowda , Department Of Pharmaceuticals , National Institution For Transforming India , Department Of Revenue , Active Pharmaceutical Ingredients , Key Starting Material , Sadanand Gowda , Transforming India , ட்வ் சாதானண்த் கவுடா , துறை ஆஃப் மருந்துகள் , தேசிய நிறுவனம் க்கு மாற்றும் இந்தியா , துறை ஆஃப் வருவாய் , செயலில் மருந்து பொருட்கள் , விசை தொடங்குகிறது பொருள் , சாதானண்த் கவுடா , மாற்றும் இந்தியா ,

Budget 2021 Expectations: Pharma Industry Seeks Steps To Reduce Dependence On API Imports From China

Budget 2021 expectations: Pharma industry seeks steps to reduce dependence on API imports from China
It is expected that the government will continue to focus on reduced import dependence, and encourage investments to boost R&D and capital expenditure.
January 08, 2021 / 10:06 PM IST
With the Union Budget for FY2022 to be presented in a few days, the pharmaceutical and API industry expects a few supportive announcements from the government that will boost growth.
It is expected that the government will continue to focus on reduced import dependence, encourage investments to boost R&D, and capital expenditure. Some of the specific areas that are likely to receive attention in the Union Budget 2021 are reducing dependence on API supplies from China, providing impetus to R&D through higher tax deductions and reducing GST rates for life saving and essential drugs. ....

Union Budget , Key Starting Material , தொழிற்சங்கம் பட்ஜெட் , விசை தொடங்குகிறது பொருள் ,